Company
United StatesPublic company, NYSE: LLYEli Lilly And Company (NYSE: LLY), Enfield, CT – FDA Inspections
Inspection records and compliance data for Eli Lilly And Company in Enfield, Connecticut. 2 FDA inspections on record, 1 warning letter, last inspected November 26, 2024. Publicly traded as NYSE: LLY.
Company Profile
This profile covers Eli Lilly And Company based in Enfield, Connecticut, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 1
First inspected February 25, 2009. Last inspected November 26, 2024.
Most cited issue areas
- Equipment Design, Size and Location1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 26, 2024 | VAI | Medical Devices & Rad Health · Compliance: Devices | 1255082 |
| February 25, 2009 | NAI | Human Drugs · Drug Quality Assurance | 571465 |
FDA documents
Warning Letters (1)
Other FDA documents (4)
People (4)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Central Admixture Pharmacy Services, Inc.
Pharmedium Services, LLC
Choice All Natural, Inc. dba Om Botanical
Allegheny Health Network Home Infusion, LLC
Ameridose, LLC
Delsam Pharma LLC
Option Care
Clean Solutions LLC
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Maryland Specialty and Compounding Pharmacy
Company Information
Name
Eli Lilly And Company
Stock ticker
LLY
Exchange
NYSE
Share price
$1,430.13
Market cap
$1.3T
Price as of
November 13, 2026
FEI Number
1250046
Address
150 Freshwater Blvd, Enfield, Connecticut 06082, United States
Country
United States
ID: 44459d0a-8580-4089-9f1a-ae1d29f195a5